Policy & Regulation
16 July 2018 - Technology continues to play a key role in the development and discovery of potential new drugs, helping to provide patients with better treatment options and increasing survival rates ...
16 July 2018 - In its published draft guidelines, the National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca's (LON: AZN) Fasenra (benralizumab) as a treatment for p...
16 July 2018 - - Malvern, Pennsylvania-based immunomodulatory technology specialist Realm Therapeutics plc (AIM: RLM) has published results of a pre-clinical study in BMC Pharmacology and Toxicology d...
16 July 2018 - - Basel, Switzerland-based clinical-stage biopharmaceutical company Myovant Sciences has completed screening patients for its LIBERTY 1 study, the first of two phase 3 replicate studies...
16 July 2018 - - Waltham, Massachusetts-based life sciences company Thermo Fisher Scientific's advanced diagnostic allergic sensitization tests will be offered by Heal, a physician house call ser...
16 July 2018 - - Salt Lake City, Utah-based biotechnology company Recursion Pharmaceuticals has received clearance from the US FDA of an investigational new drug application (iNDA) for a phase 1 clini...